Table 1.

IEI associated with AAN-I-IFN

IEIAffected gene (inheritance)Primary cellular defectPrevalence AAN-I-IFNAAN against other cytokines
APS-1 AIRE (AR) AIRE+ mTEC 97% IL-17A, IL-17F, IL-22, IFN-λ1 
RAG deficiency RAG1 or RAG2 (AR) T-lymphocytes 50% TNF-α, IL-1Ra, IL-6, IL-12p70, IL-17A, IL-17B, IL-17D, CCL1, IFN-γ, IFN-λ 1, IFN-λ2 
IPEX FOXP3 (X-linked recessive) Treg 83% IL-17A 
NF-κB2 deficiencya NFKB2 (AD) AIRE+ mTEC 59%  
NIK deficiency NIK (AR) AIRE+ mTEC 100%  
RELB deficiency RELB (AR) AIRE+ mTEC 87%  
IP NEMO (X-linked dominant) 36%  
IEIAffected gene (inheritance)Primary cellular defectPrevalence AAN-I-IFNAAN against other cytokines
APS-1 AIRE (AR) AIRE+ mTEC 97% IL-17A, IL-17F, IL-22, IFN-λ1 
RAG deficiency RAG1 or RAG2 (AR) T-lymphocytes 50% TNF-α, IL-1Ra, IL-6, IL-12p70, IL-17A, IL-17B, IL-17D, CCL1, IFN-γ, IFN-λ 1, IFN-λ2 
IPEX FOXP3 (X-linked recessive) Treg 83% IL-17A 
NF-κB2 deficiencya NFKB2 (AD) AIRE+ mTEC 59%  
NIK deficiency NIK (AR) AIRE+ mTEC 100%  
RELB deficiency RELB (AR) AIRE+ mTEC 87%  
IP NEMO (X-linked dominant) 36%  
a

p52LOF/IκBδGOF deficiency. AR autosomal recessive. AD autosomal dominant.

or Create an Account

Close Modal
Close Modal